Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone

Combined Application of Lenalidomide and Desamethasone in the Palliative Therapy of Patients With Multiple Myeloma

Purpose of this non-interventional study is the documentation of efficacy and safety data of multiple myeloma therapy with a combined treatment of Lenalidomide and Dexamethasone in daily routine practice.

Inclusion Criteria:

• Patients with multiple myeloma with at least one previous therapy.
• 18 years or older
• Signed, written informed consent

Exclusion Criteria:

• Pregnancy or nursing
• All other exclusion criteria listed in SmPC (summary of product characteristics)